医保支出增长与急性心肌梗死患者死亡率的关系:1999至2014年比较
该研究基于1999至2014年医保索赔数据,分析1220家医院急性心梗患者180天支出增长与死亡率的关系。结果显示,早期PCI增长与死亡率下降相关,心脏操作支出与死亡率正相关,出院后护理支出具中等成本效果,总体支出增长与健康改善无关。
要点
- 早期PCI增长与急性心梗患者180天死亡率下降相关。
- 心脏操作支出增长与180天死亡率升高正相关。
核心结论
- 急性心梗患者的健康改善与成本有效干预(如早期PCI和出院后护理)的推广相关,而非总体支出增长。
主要发现
- 调整后人均支出从1999-2000年至2013-2014年增加13.9%,但2008年至2013-2014年下降0.5%。
- 早期PCI增长与180天病死率呈负相关。
- 心脏操作支出与180天死亡率呈正相关。
临床怎么用
- 医院应优先推广成本有效的干预措施如早期PCI和出院后护理,而非单纯增加总体支出。
- 减少成本 ineffective 的医疗操作(院内及院外)可能同时改善结局并降低支出。
局限性
- 研究为观察性横断面分析,无法确立因果关系。
- 仅纳入按服务收费的医保受益人,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Many studies have considered the association between Medicare spending and health outcomes at a point in time; few have considered the association between the long-term growth in spending and outcomes. OBJECTIVE: To assess whether components of growth in Medicare expenditures are associated with mortality rates between January 1, 1999, and June 30, 2014, for beneficiaries hospitalized for acute myocardial infarction. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analysis of a random 20% sample of fee-for-service Medicare beneficiaries from January 1, 1999, through December 31, 2000 (n=72 473) and January 1, 2004, through December 31, 2004 (n=38 248), and 100% sample from January 1, 2008, through December 31, 2008 (n=159 558) and January 1, 2013, through June 30, 2014 (n=209 614) admitted with acute myocardial infarction to 1220 hospitals. MAIN OUTCOMES AND MEASURES: Primary exposure measures include the growth of 180-day expenditure components (eg, inpatient, physician, and postacute care) and early percutaneous coronary intervention by hospitals adjusted for price differences and inflation. The primary outcome is the risk-adjusted 180-day case fatality rate. RESULTS: Patients in each of the years 2004, 2008, and 2013-2014 (relative to those in 1999-2000) were qualitatively of equivalent age, less likely to be white or female, and more likely to be diabetic (all P < .001). Adjusted expenditures per patient increased 13.9% from January 1, 1999, through December 31, 2000, and January 1, 2013, through June 30, 2014, but declined 0.5% between 2008 and 2013-2014. Mean (SD) expenditures in the 5.0% of hospitals (n = 61) with the most rapid expenditure growth between 1999-2000 and 2013-2014 increased by 44.1% ($12 828 [$2315]); for the 5.0% of hospitals with the slowest expenditure growth (n = 61), mean expenditures decreased by 18.7% (-$7384 [$4141]; 95% CI, $8177-$6496). The growth in early percutaneous coronary intervention exhibited a negative association with 180-day case fatality. Spending on cardiac procedures was positively associated with 180-day mortality, while postacute care spending exhibited moderate cost-effectiveness ($455 000 per life saved after 180 days; 95% CI, $323 000-$833 000). Beyond spending on noncardiac procedures, growth in other components of spending was not associated with health improvements. CONCLUSIONS AND RELEVANCE: Health improvements for patients with acute myocardial infarction varied across hospitals and were associated with the diffusion of cost-effective care, such as early percutaneous coronary intervention and, to a lesser extent, postacute care, rather than overall expenditure growth. Interventions designed to promote hospital adoption of cost-effective care could improve patient outcomes and, if accompanied by cuts in cost-ineffective care (inside and outside of the hospital setting), also reduce expenditures.
引用
- Likosky DS, Van Parys J, Zhou W, et al. Association Between Medicare Expenditure Growth and Mortality Rates in Patients With Acute Myocardial Infarction: A Comparison From 1999 Through 2014. JAMA Cardiol. 2018. PMID: 29261829. doi:10.1001/jamacardio.2017.4771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。